Follow the Helix BioPharma Corp. share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the authority of SEDI. Operating in the Health Care sector, Helix BioPharma Corp. has published 11 insider filings. Market capitalisation: €142.8m. The latest transaction was disclosed on 10 August 2026 (55 - Expiration of warrants). Among the most active insiders: Wilczewski, Jerzy. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.